Just to clarify what I meant, it's the regulatory aspect. The FDA wouldn't even accept a new drug application for the indication of "longevity" or "lifespan" or

Just to clarify what I meant, it's the regulatory aspect. The FDA wouldn't even accept a new drug application for the indication of "longevity" or "lifespan" or anything like that. It wasn't considered a valid target / disease.